Compare AIN & RXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AIN | RXRX |
|---|---|---|
| Founded | 1895 | 2013 |
| Country | United States | United States |
| Employees | 5700 | N/A |
| Industry | Textiles | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 1.9B |
| IPO Year | 1994 | 2021 |
| Metric | AIN | RXRX |
|---|---|---|
| Price | $74.50 | $3.67 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 4 | 4 |
| Target Price | ★ $60.25 | $7.50 |
| AVG Volume (30 Days) | 281.4K | ★ 20.2M |
| Earning Date | 04-30-2026 | 05-06-2026 |
| Dividend Yield | ★ 1.93% | N/A |
| EPS Growth | N/A | ★ 14.79 |
| EPS | ★ 0.54 | N/A |
| Revenue | ★ $1,054,132,000.00 | $74,681,000.00 |
| Revenue This Year | $1.20 | $12.11 |
| Revenue Next Year | N/A | $82.52 |
| P/E Ratio | $139.80 | ★ N/A |
| Revenue Growth | 7.29 | ★ 26.92 |
| 52 Week Low | $41.15 | $2.77 |
| 52 Week High | $76.56 | $7.18 |
| Indicator | AIN | RXRX |
|---|---|---|
| Relative Strength Index (RSI) | 68.10 | 61.69 |
| Support Level | $53.47 | $2.88 |
| Resistance Level | N/A | $4.01 |
| Average True Range (ATR) | 2.33 | 0.21 |
| MACD | 0.24 | 0.05 |
| Stochastic Oscillator | 82.60 | 93.04 |
Albany International Corp is a textiles and materials processing company specializing in engineered fabrics and composite components and assemblies for the paper, industrial manufacturing and aerospace industries. It operates through two segments: Machine Clothing, which produces custom-designed fabrics and high-speed process belts for paper, paperboard, tissue, towel and pulp, as well as engineered fabrics for other industrial applications, and contributes the majority of revenue; and Albany Engineered Composites, which provides engineered composite parts for the aerospace and defense industries. The company generates revenue from the United States, Switzerland, Brazil, China, Mexico, France and other areas.
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery. Geographically, the company operates in United States, United Kingdom, and Others. It derives maximum revenue from United States.